2.9000 -0.04 (-1.36%)
After hours: 4:25PM EDT
|Bid||2.9000 x 3100|
|Ask||3.0000 x 900|
|Day's Range||2.9000 - 3.1600|
|52 Week Range||2.4100 - 39.4000|
|Beta (3Y Monthly)||-0.35|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Savara's (SVRA) lead pipeline candidate, Molgradex, fails to meet primary endpoint in a phase III study evaluating it in a rare autoimmune lung disorder.
Zoom Technologies Inc (OTC: ZOOM ) traded higher by as much as 120 percent Thursday morning after popular video and audio platform Zoom Video Communications Inc (NASDAQ: ZM ) held its highly anticipated ...
On a per-share basis, the Zug, Switzerland-based company said it had a loss of 12 cents. For the year, the company reported that its loss narrowed to $11.8 million, or 74 cents per share. The company's ...
On a per-share basis, the Zug, Switzerland-based company said it had a loss of 14 cents. The company's shares closed at 63 cents. A year ago, they were trading at $7.39. _____ This story was generated ...
Auris Medical stock (NASDAQ:EARS) went gangbusters to kick off the week even though the company did not have any announcements or news surrounding it on Monday.